Literature DB >> 3180371

Emergency stenting for acute occlusion after coronary balloon angioplasty.

U Sigwart1, P Urban, S Golf, U Kaufmann, C Imbert, A Fischer, L Kappenberger.   

Abstract

Acute coronary artery occlusion complicates 2-12% of the balloon angioplasty procedures, and despite repeat angioplasty, emergency surgical revascularization is often necessary. We report our initial experience with the emergency implantation of endoluminal stents for acute vessel closure after coronary balloon angioplasty. Nine patients received one stent, and two patients received two stents during the study period. Implantation was technically successful in all patients; there were no deaths, no myocardial infarctions as evidenced by Q wave on the electrocardiogram, and no need for emergency surgery. One additional patient, not satisfying the study inclusion criteria, died 16 hours after stent implantation from left ventricular failure and intractable arrythmias. Two patients in the study group had a moderate creatinine phosphokinase rise during the first 48 hours after implantation. During a median follow-up period of 3 months (range, 1-20 months), there have been no deaths and no need for elective coronary bypass surgery. One patient required emergency recanalization 3 months after implantation because of acute occlusion of the stented segment with limited myocardial infarction. Six patients have undergone control angiography, and none has developed chronic restenosis within the stented segment. For selected patients, coronary artery stenting appears to be a promising alternative to emergency bypass surgery after acute vessel occlusion during balloon angioplasty.

Entities:  

Mesh:

Year:  1988        PMID: 3180371     DOI: 10.1161/01.cir.78.5.1121

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  24 in total

Review 1.  Stent thrombosis: historical perspectives and current trends.

Authors:  D E Cutlip
Journal:  J Thromb Thrombolysis       Date:  2000-08       Impact factor: 2.300

Review 2.  Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.

Authors:  Shann S Yu; Ryan A Ortega; Brendan W Reagan; John A McPherson; Hak-Joon Sung; Todd D Giorgio
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-08-10

3.  Percutaneous transluminal coronary angioplasty: what next?

Authors:  U Sigwart
Journal:  Br Heart J       Date:  1990-06

4.  Emergency coronary artery stenting for coronary dissection complicating diagnostic cardiac catheterisation.

Authors:  C Knight; R Stables; U Sigwart
Journal:  Br Heart J       Date:  1995-08

5.  Changes in membrane glycoproteins of circulating platelets after coronary stent implantation.

Authors:  M Gawaz; F J Neumann; I Ott; A May; S Rüdiger; A Schömig
Journal:  Heart       Date:  1996-08       Impact factor: 5.994

Review 6.  Coronary artery stents.

Authors:  A J Stewart; D J Coltart
Journal:  Postgrad Med J       Date:  1996-05       Impact factor: 2.401

Review 7.  Bioresorbable Scaffolds for Coronary Artery Disease.

Authors:  Ashwin Nathan; Taisei Kobayashi; Daniel M Kolansky; Robert L Wilensky; Jay Giri
Journal:  Curr Cardiol Rep       Date:  2017-01       Impact factor: 2.931

Review 8.  Bioresorbable Scaffolds: Current Evidences in the Treatment of Coronary Artery Disease.

Authors:  Bhargav Dave
Journal:  J Clin Diagn Res       Date:  2016-10-01

9.  Bioresorbable scaffold-the holy grail of percutaneous coronary intervention: fact or myth?

Authors:  Kevin Liou; Nigel Jepson
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

10.  Temporary stent as a bail-out device during percutaneous transluminal coronary angioplasty: preliminary clinical experience.

Authors:  J S Gibbs; U Sigwart; N P Buller
Journal:  Br Heart J       Date:  1994-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.